rdf:type |
|
lifeskim:mentions |
umls-concept:C0007138,
umls-concept:C0030705,
umls-concept:C0036525,
umls-concept:C0045093,
umls-concept:C0205082,
umls-concept:C0205195,
umls-concept:C0246415,
umls-concept:C0332293,
umls-concept:C0600688,
umls-concept:C1522484,
umls-concept:C2709248
|
pubmed:issue |
8
|
pubmed:dateCreated |
1999-11-16
|
pubmed:abstractText |
Both gemcitabine and docetaxel have been associated with pulmonary toxicity when used as single agents. We report a study in which three of five cases developed pulmonary toxicity (which proved fatal in one case) when these drugs were used in combination to treat metastatic transitional cell cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0923-7534
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
943-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10509156-Aged,
pubmed-meshheading:10509156-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10509156-Carcinoma, Transitional Cell,
pubmed-meshheading:10509156-Deoxycytidine,
pubmed-meshheading:10509156-Dyspnea,
pubmed-meshheading:10509156-Fatal Outcome,
pubmed-meshheading:10509156-Humans,
pubmed-meshheading:10509156-Lung,
pubmed-meshheading:10509156-Male,
pubmed-meshheading:10509156-Middle Aged,
pubmed-meshheading:10509156-Neoplasm Staging,
pubmed-meshheading:10509156-Paclitaxel,
pubmed-meshheading:10509156-Severity of Illness Index,
pubmed-meshheading:10509156-Taxoids,
pubmed-meshheading:10509156-Treatment Outcome,
pubmed-meshheading:10509156-Urinary Bladder Neoplasms
|
pubmed:year |
1999
|
pubmed:articleTitle |
Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma.
|
pubmed:affiliation |
CRC Wessex Medical Oncology Unit, Department of Histopathology and Radiology, Southampton University Hospitals, UK.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Case Reports,
Clinical Trial, Phase I
|